Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Using credit card points for vacation packages can lead to significant savings. Discover how to make the most of your rewards for a dream trip.
17,930 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
A major advisory firm made a multi-million dollar bet in a large-cap growth ETF, catching the eye of everyday investo...
RE/MAX faces a changing housing landscape as it grows internationally. President Chris Lim outlines a strategy built ...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Brand resilience is a key factor for investors. This article examines Unity Software and Zillow to see if they stand ...
As Agora releases Q4 2025 data, investors will watch API growth, customer momentum, and profitability signals. This g...
Snowflake has delivered strong results, yet the stock has pulled back. This guide explains what snowflake shows signs...
February highlighted a split in space stocks: Iridium rose on stabilizing results, while Redwire and Spacemobile tumb...
A coalition of Democratic attorneys general filed lawsuits seeking refunds on tariffs imposed under a new Section 122...